Expression and characterization of a functional canine variant of cytochrome b5 reductase
- PMID: 16814740
- DOI: 10.1016/j.abb.2006.04.021
Expression and characterization of a functional canine variant of cytochrome b5 reductase
Abstract
Cytochrome b5 reductase (cb5r), a member of the flavoprotein transhydrogenase family of oxidoreductase enzymes, catalyzes the transfer of reducing equivalents from the physiological electron donor, NADH, to two molecules of cytochrome b5. We have determined the correct nucleotide sequence for the putative full-length, membrane-associated enzyme from Canis familiaris, and have generated a heterologous expression system for production of a histidine-tagged variant of the soluble, catalytic diaphorase domain, comprising residues I33 to F300. Using a simple two-step chromatographic procedure, the recombinant diaphorase domain has been purified to homogeneity and demonstrated to be a simple flavoprotein with a molecular mass of 31,364 (m/z) that retained both NADH:ferricyanide reductase and NADH:cytochrome b5 reductase activities. The recombinant protein contained a full complement of FAD and exhibited absorption and CD spectra comparable to those of a recombinant form of the rat cytochrome b5 reductase diaphorase domain generated using an identical expression system, suggesting similar protein folding. Oxidation-reduction potentiometric titrations yielded a standard midpoint potential (Eo') for the FAD/FADH2 couple of -273+/-5 mV which was identical to the value obtained for the corresponding rat domain. Thermal denaturation studies revealed that the canine domain exhibited stability comparable to that of the rat protein, confirming similar protein conformations. Initial-rate kinetic studies revealed the canine diaphorase domain retained a marked preference for NADH versus NADPH as reducing substrate and exhibited kcat's of 767 and 600 s(-1) for NADH:ferricyanide reductase and NADH:cytochrome b5 reductase activities, respectively, with Km's of 7, 8, and 12 microM for NADH, K3Fe(CN)6, and cytochrome b5, respectively. Spectral-binding constants (Ks) determined for a variety of NAD+ analogs indicated the highest and lowest affinities were observed for APAD+ (Ks=71 microM) and PCA+ (Ks=>31 mM), respectively, and indicated the binding contributions of the various portions of the pyridine nucleotide. These results provide the first correct sequence for the full-length, membrane-associated form of C. familiaris cb5r and provide a direct comparison of the enzymes from two phylogenetic sources using identical expression systems that indicate that both enzymes have comparable spectroscopic, kinetic, thermodynamic, and structural properties.
Similar articles
-
Cytochrome b5 reductase: the roles of the recessive congenital methemoglobinemia mutants P144L, L148P, and R159*.Arch Biochem Biophys. 2004 Nov 15;431(2):233-44. doi: 10.1016/j.abb.2004.08.005. Arch Biochem Biophys. 2004. PMID: 15488472
-
Mutagenesis of Glycine 179 modulates both catalytic efficiency and reduced pyridine nucleotide specificity in cytochrome b5 reductase.Biochemistry. 2005 Oct 18;44(41):13467-76. doi: 10.1021/bi051165t. Biochemistry. 2005. PMID: 16216070
-
Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.Arch Biochem Biophys. 2002 Apr 1;400(1):63-75. doi: 10.1006/abbi.2002.2783. Arch Biochem Biophys. 2002. PMID: 11913972
-
Human cytochrome b5 reductase: structure, function, and potential applications.Crit Rev Biotechnol. 2014 Jun;34(2):134-43. doi: 10.3109/07388551.2012.732031. Epub 2012 Nov 1. Crit Rev Biotechnol. 2014. PMID: 23113554 Review.
-
Structural Features of Cytochrome b5-Cytochrome b5 Reductase Complex Formation and Implications for the Intramolecular Dynamics of Cytochrome b5 Reductase.Int J Mol Sci. 2021 Dec 23;23(1):118. doi: 10.3390/ijms23010118. Int J Mol Sci. 2021. PMID: 35008543 Free PMC article. Review.
Cited by
-
Familial Congenital Methemoglobinemia in Pomeranian Dogs Caused by a Missense Variant in the NADH-Cytochrome B5 Reductase Gene.J Vet Intern Med. 2018 Jan;32(1):165-171. doi: 10.1111/jvim.15031. Epub 2018 Jan 22. J Vet Intern Med. 2018. PMID: 29356095 Free PMC article.
-
Characterization of a novel nicotinamide adenine dinucleotide-cytochrome b5 reductase mutation associated with canine hereditary methemoglobinemia.J Vet Med Sci. 2021 Mar 5;83(2):315-321. doi: 10.1292/jvms.20-0390. Epub 2020 Dec 21. J Vet Med Sci. 2021. PMID: 33342963 Free PMC article.
-
NADH-dependent cytochrome b5 reductase and NADPH methemoglobin reductase activity in the erythrocytes of Oncorhynchus mykiss.Fish Physiol Biochem. 2012 Dec;38(6):1807-1813. doi: 10.1007/s10695-012-9677-2. Epub 2012 Jun 26. Fish Physiol Biochem. 2012. PMID: 22733093
-
Evaluation of polymorphisms in the sulfonamide detoxification genes CYB5A and CYB5R3 in dogs with sulfonamide hypersensitivity.J Vet Intern Med. 2012 Sep-Oct;26(5):1126-33. doi: 10.1111/j.1939-1676.2012.00965.x. Epub 2012 Jul 21. J Vet Intern Med. 2012. PMID: 22816446 Free PMC article.
-
The Zebrafish Cytochrome b5/Cytochrome b5 Reductase/NADH System Efficiently Reduces Cytoglobins 1 and 2: Conserved Activity of Cytochrome b5/Cytochrome b5 Reductases during Vertebrate Evolution.Biochemistry. 2019 Jul 23;58(29):3212-3223. doi: 10.1021/acs.biochem.9b00406. Epub 2019 Jul 10. Biochemistry. 2019. PMID: 31257865 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources